SEARCH

SEARCH BY CITATION

References

  • Ahringer, J. (2000) NuRD and SIN3 histone deacetylase complexes in development. Trends in Genetics, 16, 351356.
  • Bartholomew, C., Kilbey, A., Clark, A., Walker, M. (1997) The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation. Oncogene, 14, 569577.
  • Bartl, S., Taplick, J., Lagger, G., Khier, H., Kuchler, K., Seiser, C. (1997) Identification of mouse histone deacetylase 1 as a growth factor-inducible gene. Molecular and Cellular Biology, 17, 50335043.
  • Chakrabarti, S. & Nucifora, G. (1999) The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A. Biochemical and Biophysical Research Communications, 264, 871877.DOI: 10.1006/bbrc.1999.1605
  • Doetzlhofer, A., Rotheneder, H., Lagger, G., Koranda, M., Kurtev, V., Brosch, G., Wintersberger, E., Seiser, C. (1999) Histone deacetylase 1 can repress transcription by binding to Sp1. Molecular and Cellular Biology, 19, 55045511.
  • Dreyfus, F., Bouscary, D., Melle, J., Ribrag, V., Guesnu, M., Varet, B. (1995) Expression of the Evi-1 gene in myelodysplastic syndromes. Leukemia, 9, 203205.
  • Fears, S., Mathieu, C., Zeleznik Le, N., Huang, S., Rowley, J., Nucifora, G. (1996) Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family. Proceedings of the National Academy of Sciences of the United States of America, 93, 16421647.
  • Fenrick, R., Amann, J., Lutterbach, B., Wang, L., Westendorf, J., Downing, J., Hiebert, S. (1999) Both TEL and AML-1 contribute repression domains to the t (12; 21) fusion protein. Molecular and Cellular Biology, 19, 65666574.
  • Fichelson, S., Dreyfus, F., Berger, R., Melle, J., Bastard, C., Miclea, J., Gisselbrecht, S. (1992) Evi-1 expression in leukemic patients with rearrangements of the 3q25-q28 chromosomal region. Leukemia, 6, 9399.
  • Fontenay Roupie, M., Bouscary, D., Melle, J., Viguie, F., Picard, F., Guesnu, M., Dreyfus, F. (1997) Expression of the transcription factor Evi-1 in human erythroleukemia cell lines and in leukemias. Hematology and Cell Therapy, 39, 510.
  • Funabiki, T., Kreider, B., Ihle, J. (1994) The carboxyl domain of zinc fingers of the Evi-1 myeloid transforming gene binds a consensus sequence of GAAGATGAG. Oncogene, 9, 15751581.
  • Gerhardt, T., Schmahl, G., Flotho, C., Rath, A., Niemeyer, C. (1997) Expression of the Evi-1 gene in haemopoietic cells of children with juvenile myelomonocytic leukaemia and normal donors. British Journal of Haematology, 99, 882887.
  • Grignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F., Zamir, I., Seiser, C., Grignani, F., Lazar, M., Minucci, S., Pelicci, P. (1998) Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature, 391, 815818.DOI: 10.1038/35901
  • Hoyt, P., Bartholomew, C., Davis, A., Yutzey, K., Gamer, L., Potter, S., Ihle, J., Mucenski, M. (1997) The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development. Mechanisms of Development, 65, 5570.DOI: 10.1016/S0925-4773(97)00057-9
  • Huang, S. & Brandt, S. (2000) mSin3a regulates murine erythroleukemia cell differentiation through association with the Tal1 (or Scl) transcription factor. Molecular and Cellular Biology, 20, 22482259.
  • Izutsu, K., Kurokawa, M., Imai, Y., Maki, K., Mitani, K., Hirai, H. (2001) The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling. Blood, 97, 28152822.
  • Jacobson, S. & Pillus, L. (1999) Modifying chromatin and concepts of cancer. Current Opinion in Genetics and Development, 9, 175184.
  • Karlseder, J., Rotheneder, H., Wintersberger, E. (1996) Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Molecular and Cellular Biology, 16, 16591667.
  • Khanna Gupta, A., Lopingco, M., Savinelli, T., Zibello, T., Berliner, N., Perkins, A. (1996) Retroviral insertional activation of the EVI1 oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line 32Dcl3. Oncogene, 12, 563569.
  • Kilbey, A. & Bartholomew, C. (1998) Evi-1 ZF1 DNA binding activity and a second distinct transcriptional repressor region are both required for optimal transformation of Rat1 fibroblasts. Oncogene, 16, 22872291.
  • Kouzarides, T. (1999) Histone acetylases and deacetylases in cell proliferation. Current Opinion in Genetics and Development, 9, 4048.
  • Kovarik, P., Mangold, M., Ramsauer, K., Heidari, H., Steinborn, R., Zotter, A., Levy, D., Müller, M., Decker, T. (2001) Specificity of signaling by STAT1 depends on SH2-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression. EMBO Journal, 20, 91100.
  • Kreider, B., Orkin, S., Ihle, J. (1993) Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene. Proceedings of the National Academy of Sciences of the United States of America, 90, 64546458.
  • Kurokawa, M., Mitani, K., Irie, K., Matsuyama, T., Takahashi, T., Chiba, S., Yazaki, Y., Matsumoto, K., Hirai, H. (1998) The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3. Nature, 394, 9296.DOI: 10.1038/27945
  • Kurokawa, M., Mitani, K., Yamagata, T., Takahashi, T., Izutsu, K., Ogawa, S., Moriguchi, T., Nishida, E., Yazaki, Y., Hirai, H. (2000) The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death. EMBO Journal, 19, 29582968.
  • Lee, J., Galvin, K., See, R., Eckner, R., Livingston, D., Moran, E., Shi, Y. (1995) Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes and Development, 9, 11881198.
  • Lin, R., Nagy, L., Inoue, S., Shao, W., Miller, W. Jr, Evans, R. (1998) Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature, 391, 811814.DOI: 10.1038/35895
  • Louz, D., Van Den Broek, M., Verbakel, S., Vankan, Y., Van Lom, K., Joosten, M., Meijer, D., Lowenberg, B., Delwel, R. (2000) Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice. Leukemia, 14, 18761884.
  • Luo, R., Postigo, A., Dean, D. (1998) Rb interacts with histone deacetylase to repress transcription. Cell, 92, 463473.
  • Martin, D. & Orkin, S. (1990) Transcriptional activation and DNA binding by the erythroid factor GF-1/NF-E1/Eryf 1. Genes and Development, 4, 18861898.
  • Matsugi, T., Kreider, B., Delwel, R., Cleveland, J., Askew, D., Ihle, J. (1995) The Evi-1 zinc finger myeloid transforming protein binds to genomic fragments containing (GATA)n sequences. Oncogene, 11, 191198.
  • Mitani, K., Ogawa, S., Tanaka, T., Miyoshi, H., Kurokawa, M., Mano, H., Yazaki, Y., Ohki, M., Hirai, H. (1994) Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO Journal, 13, 504510.
  • Morishita, K., Parker, D., Mucenski, M., Jenkins, N., Copeland, N., Ihle, J. (1988) Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell, 54, 831840.
  • Morishita, K., Parganas, E., Douglass, E., Ihle, J. (1990) Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts. Oncogene, 5, 963971.
  • Morishita, K., Parganas, E., Willman, C., Whittaker, M., Drabkin, H., Oval, J., Taetle, R., Valentine, M., Ihle, J. (1992a) Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300–400 kilobases on chromosome band 3q26. Proceedings of the National Academy of Sciences of the United States of America, 89, 39373941.
  • Morishita, K., Parganas, E., Matsugi, T., Ihle, J. (1992b) Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor. Molecular and Cellular Biology, 12, 183189.
  • Morishita, K., Suzukawa, K., Taki, T., Ihle, J., Yokota, J. (1995) EVI-1 zinc finger protein works as a transcriptional activator via binding to a consensus sequence of GACAAGATAAGATAAN1−28 CTCATCTTC. Oncogene, 10, 19611967.
  • Nucifora, G., Begy, C., Kobayashi, H., Roulston, D., Claxton, D., Pedersen-Bjergaard, J., Parganas, E., Ihle, J., Rowley, J. (1994) Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21) (q26;q22) translocations. Proceedings of the National Academy of Sciences of the United States of America, 91, 40044008.
  • Ogawa, S., Kurokawa, M., Tanaka, T., Tanaka, K., Hangaishi, A., Mitani, K., Kamada, N., Yazaki, Y., Hirai, H. (1996) Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia. Leukemia, 10, 788794.
  • Peeters, P., Wlodarska, I., Baens, M., Criel, A., Selleslag, D., Hagemeijer, A., Van den Berghe, H., Marynen, P. (1997) Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders. Cancer Research, 57, 564569.
  • Perkins, A. & Kim, J. (1996) Zinc fingers 1–7 of EVI1 fail to bind to the GATA motif by itself but require the core site GACAAGATA for binding. Journal of Biological Chemistry, 271, 11041110.DOI: 10.1074/jbc.271.2.1104
  • Redner, R., Wang, J., Liu, J. (1999) Chromatin remodeling and leukemia: New therapeutic paradigms. Blood, 94, 417428.
  • Russell, M., List, A., Greenberg, P., Woodward, S., Glinsmann, B., Parganas, E., Ihle, J., Taetle, R. (1994) Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. Blood, 84, 12431248.
  • Soderholm, J., Kobayashi, H., Mathieu, C., Rowley, J., Nucifora, G. (1997) The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator. Leukemia, 11, 352358.
  • Sood, R., Talwar Trikha, A., Chakrabarti, S., Nucifora, G. (1999) MDS1/EVI1 enhances TGF-beta 1 signaling and strengthens its growth-inhibitory effect, but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t (3; 21), abrogates growth-inhibition in response to TGF-beta 1. Leukemia, 13, 348357.
  • Sun, H. & Taneja, R. (2000) Stra13 expression is associated with growth arrest and represses transcription through histone deacetylase (HDAC) -dependent and HDAC-independent mechanisms. Proceedings of the National Academy of Sciences of the United States of America, 97, 40584063.
  • Suzukawa, K., Parganas, E., Gajjar, A., Abe, T., Takahashi, S., Tani, K., Asano, S., Asou, H., Kamada, N., Yokota, J., Morishita, K., Ihle, J. (1994) Identification of a breakpoint cluster region 3′ of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv (3) (q21q26). Blood, 84, 26812688.
  • Testoni, N., Borsaru, G., Martinelli, G., Carboni, C., Ruggeri, D., Ottaviani, E., Pelliconi, S., Ricci, P., Pastano, R., Visani, G., Zaccaria, A., Tura, S. (1999) 3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features. Haematologica, 84, 690694.
  • Turner, J. & Crossley, M. (1998) Cloning and characterization of mCtBP2, a co-repressor that associates with basic Kruppel-like factor and other mammalian transcriptional regulators. EMBO Journal, 17, 51295140.
  • Wang, J., Hoshino, T., Redner, R., Kajigaya, S., Liu, J. (1998) ETO, fusion partner in t (8; 21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proceedings of the National Academy of Sciences of the United States of America, 95, 1086010865.
  • Wang, J., Saunthararajah, Y., Redner, R., Liu, J. (1999) Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells. Cancer Research, 59, 27662769.
  • Warrell, R., He, L., Richon, V., Calleja, E., Pandolfi, P. (1998) Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. Journal of the National Cancer Institute, 90, 16211625.DOI: 10.1093/jnci/90.21.1621
  • Wimmer, K., Vinatzer, U., Zwirn, P., Fonatsch, C., Wieser, R. (1998) Comparative expression analysis of the antagonistic transcription factors EVI1 and MDS1-EVI1 in murine tissues and during in vitro hematopoietic differentiation. Biochemical and Biophysical Research Communications, 252, 691696.DOI: 10.1006/bbrc.1998.9588
  • Wotton, D., Lo, R., Swaby, L., Massague, J. (1999) Multiple modes of repression by the Smad transcriptional corepressor TGIF. Journal of Biological Chemistry, 274, 3710537110.DOI: 10.1074/jbc.274.52.37105
  • Xi, Z., Russell, M., Woodward, S., Thompson, F., Wagner, L., Taetle, R. (1997) Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia. Leukemia, 11, 212220.